Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretio...
Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion
About this item
Full title
Author / Creator
Zhao, Min , Liao, Baoying , Yun, Chuyu , Qi, Xinyu and Pang, Yanli
Publisher
London: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central
Subjects
More information
Scope and Contents
Contents
Background
At present, a number of clinical trials have been carried out on GLP-1 receptor agonist liraglutide in the treatment of polycystic ovary syndrome (PCOS). However, the effect of liraglutide on follicle development and its specific mechanism are still unclear.
Methods
RNA sequencing was used to explore the molecular characteristic...
Alternative Titles
Full title
Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0a87cf99b9174367991edf9b5e9b910a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0a87cf99b9174367991edf9b5e9b910a
Other Identifiers
ISSN
1477-7827
E-ISSN
1477-7827
DOI
10.1186/s12958-024-01269-9
